PReS13-SPK-1579: Biologic agents for the treatment of rheumatic diseases

被引：0
|
作者：
P Emery
机构：
[1] University of Leeds,
来源：
Pediatric Rheumatology | / 11卷 / Suppl 2期
关键词：
Public Health; Rheumatoid Arthritis; Arthritis; Methotrexate; Rheumatic Disease;
D O I：
10.1186/1546-0096-11-S2-I27
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] PReS13-SPK-1586: Biological agents for the treatment of rheumatic diseases: present and future targets of biologic therapy
    I Mcinnes
    [J]. Pediatric Rheumatology, 11 (Suppl 2)
  • [2] PReS13-SPK-1129: Biologic therapies in SLE
    DA Isenberg
    [J]. Pediatric Rheumatology, 11 (Suppl 2)
  • [3] Upcoming biologic agents for the treatment of rheumatic diseases
    Shanahan, JC
    Moreland, LW
    Carter, RH
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2003, 15 (03) : 226 - 236
  • [4] PReS13-SPK-1321: Expanding clinical spectrum of autoinflammatory diseases
    I Aksentijevich
    [J]. Pediatric Rheumatology, 11 (Suppl 2)
  • [5] OPTIMIZING TREATMENT OF RHEUMATIC DISEASES WITH BIOLOGIC AGENTS IN OUR DAY HOSPITAL
    Calvo, J.
    Castro, M. D. C.
    Escudero, A.
    Collantes Estevez, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 934 - 934
  • [6] Use of biologic agents for rheumatic diseases in pregnancy
    Yesim Garip
    [J]. World Journal of Rheumatology, 2015, (02) : 50 - 58
  • [7] PReS13-SPK-1576: Unmeet needs in JIA treatment
    N Ruperto
    [J]. Pediatric Rheumatology, 11 (Suppl 2)
  • [8] PReS13-SPK-1587: New biologic targets for the future and basic science behind them
    B Prakken
    [J]. Pediatric Rheumatology, 11 (Suppl 2)
  • [9] Central demyelination due to biologic agents in rheumatic diseases
    Arslan, D.
    Sayinalp-Arslan, B.
    Acar-Ozen, P.
    Bilgin, E.
    Ertenli, I.
    Kiraz, S.
    Kalyoncu, U.
    Karabudak, R.
    Tuncer, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 453 - 453
  • [10] BIOLOGIC AGENTS IN RHEUMATIC DISEASES - A REAL LIFE EXPERIENCE
    Stanic, M.
    Skocibusic, N.
    Zekic, T.
    Novak, S.
    Vlahovic-Palcevski, V.
    [J]. CLINICAL THERAPEUTICS, 2015, 37 (08) : E42 - E43
12345